期刊文献+

RNA编辑酶ADAR1在大鼠肝移植排斥反应中的变化 被引量:1

ADAR1 Expression in Acute Rejection of Liver Transplantation in Rats
下载PDF
导出
摘要 目的观察RNA编辑酶ADAR1在大鼠肝移植排斥反应中的表达变化。方法实验分为4组①同基因移植组(n=15),取Wistar大鼠的肝脏原位移植给Wistar大鼠;②异基因移植组(n=15),取SD大鼠的肝脏移植给Wistar大鼠;③异基因移植+FK506治疗组(n=15),取SD大鼠的肝脏移植给Wistar大鼠,术后肌注FK506,2mg/(kg·d);④对照组(n=15),对Wistar大鼠不行肝移植,仅行开、关腹手术。建立大鼠原位肝移植模型,分别于术后第3、5及7d各处死5只大鼠,取脾脏组织,用RT-PCR方法检测ADAR1 mRNA的表达变化。结果移植后各组大鼠肝脏、脾脏病理变化随时间发展而呈进行性变化,异基因移植组病理变化最明显。ADAR1 mRNA表达在异基因移植组的各个时相点明显高于同基因移植组和异基因移植+FK506治疗组(P<0.001),于第5d时最明显。结论在大鼠原位肝移植发生急性排斥反应时,ADAR1增高程度与排斥反应的强度变化趋势一致。FK506可以抑制ADAR1的表达,明显减轻移植肝组织的急性排斥反应。 Objective To investigate the expression of RNA editase ADAR1 in the lymphocytes in rats' spleen with liver transplantation rejection. Methods Thirty SD rats and 75 Wistar rats were included. Fifteen livers from Wistar rats were transplanted to 15 Wistar rats (isograft group), 30 livers from SD rats were transplanted to 30 Wistar rats (allograft group and allograft+ FK506 group), and 15 of them were then intramuscularly injected with FK506, 2 mg/(kg · d), the other 15 Wistar rats were only operated similarly to the other rats without any liver transplantation (control group). Five rats were killed and their splenetic tissues were collected on day 3, day 5, and day 7, respectively. The expression of ADAR1 mRNA in lymphocytes of the spleen in acute rejection was detected by RT-PCR. Results Different performance of pathology was observed in all the liver and spleen tissues from the transplanted rats over time, especially in allograft group. The expression of ADAR1 mRNA in the allograft group was significant higher than that of isograft and allograft+FK506 groups (P〈0. 001), especially on the 5th day. Conclusion There was a significant positive correlation between expression of ADAR1 and the severity of acute rejection, but the mechanism by which ADAR1 affected the acute rejection is unknown and needs to be further studied. FK506 may inhibit the expression of ADAR1 and remarkably reduce the severity of acute rejection.
出处 《中国普外基础与临床杂志》 CAS 2007年第2期134-137,共4页 Chinese Journal of Bases and Clinics In General Surgery
基金 国家自然科学基金项目(编号:30271281 30170923)~~
关键词 RNA编辑酶 大鼠 肝移植 排斥反应 RNA editase Rat Liver transplantation Rejection
  • 相关文献

参考文献11

二级参考文献37

  • 1孔亚林,窦科峰,张洪涛,冯全新,张福琴,赵青川.共培养体系中小鼠淋巴细胞RNA编辑酶的表达[J].第四军医大学学报,2006,27(5):392-395. 被引量:4
  • 2[1]Patterson JB,Thomas DC,Hans SL,et al.Mechanism of interferon action:double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons[J].Virology,1995,210(2):508-511.
  • 3[2]Rabinovici R,Kabir K,Chen M,et al.ADAR1 is involved in the development of microvascular lung injury[J].Circ Res,2001,88(10):1066-1071.
  • 4[3]Yang JH,Sklar P,Axel R,et al.Editing of glutamate receptor subunit B pre-mRNA in vitro by site-specific deamination of adenosine[J].Nature,1995,374:77-81.
  • 5[4]Sprengel R,Higuchi M,Monyer H,et al.Glutamate receptor channels:a possible link between RNA editing in the brain an epilepsy[J].Adv Neurol,1999,79:525-534.
  • 6[5]Van den Leeuwen FW,de Kleijn DP,van den Hurk HH.Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and down patients[J].Science,1998,279(5348):242-247.
  • 7[6]Wang Q,Khilan J,Gradue P,et al.Requirement of the RNA editing deaminase ADAR1 gen for embryonic erythropoiesi[J].Science,2000,290(5497):1765-17688.
  • 8[1]Niswender C M. Recent advances in mammalian RNA editing. Cell Mol Life Sci, 1998, 54: 946~964
  • 9[2]Brennicke A, Marchfelder A, Binder S. RNA editing. FEMS Microbiol Rev, 1999, 23: 297~316
  • 10[3]Bass B L. RNA editing and hypermutation by adenosine deamination. TIBS, 1997, 22: 157~162

共引文献33

同被引文献19

  • 1谈燚,黄陈,李宗狂,高涌,刘会春,刘金新.提高二袖套法大鼠原位肝移植成功率的手术技巧[J].中国普外基础与临床杂志,2004,11(5):405-407. 被引量:4
  • 2陈耿,张玉君,杨程,郑树国,李昆,董家鸿.重建肝动脉血液供应和胆道外引流的大鼠原位肝移植模型的建立[J].中华器官移植杂志,2006,27(1):40-43. 被引量:12
  • 3姜英,王业华,贾筱琴,俞俊杰,张清莉,杨树民.外周血CTL活化基因在大鼠肾移植急性排斥的表达及意义[J].南京医科大学学报(自然科学版),2006,26(2):108-112. 被引量:2
  • 4Kamada N, Calne RY. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage [J]. Transplantation, 1979 , 28(1): 47-50.
  • 5Demetrius AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: an international consensus document [J]. Hepatology, 1997,25(3): 658-663.
  • 6Lefkowitch JH. Diagnostic issues in liver transplantation pathology [J].Clin Liver Dis, 2002, 6(2): 555-570.
  • 7Krams SM, Ascher NL, Martinez OM. New immunologic insights into mechanisms of allograft rejection [J]. Gastroenterol Clin North Am, 1993,22(2):381-400.
  • 8Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States [J]. N Engl J Med, 2000, 342(9): 605-612.
  • 9Bernard A, Lamy And L, Alberti I. The two-signal model of T cell activation after 30 years [J]. Transplantation, 2002, 73(1 Suppl) : S31-S35.
  • 10Olive C, Cheung C, Falk MC. Apoptosis and expression of cytotoxie T lymphocyte effector molecules in renal allografts [J]. Transpl Immunol, 1999, 7(1) : 27-36.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部